Polyphenol Interactions with Gut Microbiota

Polyphenols are a chemically diverse group of plant secondary metabolites that exert multiple bioactive functions in human health. Upon ingestion, a substantial fraction of dietary polyphenols escapes absorption in the upper gastrointestinal tract and reaches the colon, where they engage in reciprocal interactions with the resident microbial community. Gut microorganisms enzymatically transform polyphenols into low-molecular-weight metabolites, enhancing their bioavailability and biological activities. Conversely, polyphenols modulate microbial composition and function: they can inhibit opportunistic pathogens, selectively stimulate the growth of beneficial taxa and influence microbial metabolic output, notably the production of short-chain fatty acids. These interactions contribute to the maintenance of intestinal barrier integrity, modulation of immune responses and regulation of host metabolism. Interindividual variability in microbial composition underpins differential responses to polyphenol intake, highlighting the need for personalised nutritional strategies. Advances in multi-omics technologies have elucidated specific enzymatic pathways responsible for polyphenol biotransformation and identified bioactive metabolites that mediate systemic effects, from anti-inflammatory actions to modulation of lipid and glucose homeostasis. This intricate polyphenol–microbiota interplay has implications for the prevention and management of chronic conditions such as obesity, metabolic syndrome and inflammatory bowel disease. Ongoing research emphasises practical applications in the design of functional foods, nutraceutical formulations and dietary guidelines aimed at harnessing polyphenol-driven modulation of the gut ecosystem for health promotion.

Research from Nature Portfolio

A foundational study investigated the impact of non-absorbable apple procyanidins in a high-fat diet mouse model. Long-term administration of these polymeric flavonoids led to a marked decrease in the Firmicutes to Bacteroidetes ratio and an eightfold increase in the mucin-degrading bacterium Akkermansia. These microbial shifts were accompanied by reduced weight gain, improved insulin sensitivity and diminished markers of inflammation. Metabolomic profiling revealed alterations in host urinary metabolites linked to lipid metabolism, implying that microbial biotransformation of polymeric polyphenols can mediate systemic metabolic benefits.

Polyphenol Interactions with Gut Microbiota publication trend

The graph below shows the total number of articles in polyphenol interactions with gut microbiota across all publications each year (not limited to Nature Index journals).

Technical terms

Polyphenol: A class of plant-derived compounds characterised by multiple phenolic rings, involved in antioxidant and microbiota-mediated activities.

Gut microbiota: The community of microorganisms resident in the gastrointestinal tract, essential for digestion, immunity and host metabolism.

Biotransformation: Microbial enzymatic conversion of dietary compounds into metabolites with altered bioactivity and bioavailability.

Prebiotic: A substrate selectively utilised by beneficial gut microbes, conferring health benefits to the host.

Short-chain fatty acids (SCFA): Microbial fermentation products such as acetate, propionate and butyrate that influence host energy metabolism and immune function.

Bioavailability: The proportion of an ingested compound that reaches systemic circulation in an active form.

References

1. The Reciprocal Interactions between Polyphenols and Gut Microbiota and Effects on Bioaccessibility. Nutrients (2016).
2. Non-absorbable apple procyanidins prevent obesity associated with gut microbial and metabolomic changes. Scientific Reports (2016).
3. Interindividual differences in aronia juice tolerability linked to gut microbiome and metabolome changes—secondary analysis of a randomized placebo-controlled parallel intervention trial. Microbiome (2024).
4. Short term supplementation with cranberry extract modulates gut microbiota in human and displays a bifidogenic effect. npj Biofilms and Microbiomes (2024).